Sabra Healthcare REIT (SBRA)
(Delayed Data from NSDQ)
$16.96 USD
+0.23 (1.37%)
Updated Dec 20, 2024 04:00 PM ET
After-Market: $16.97 +0.01 (0.06%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth D Momentum D VGM
Price, Consensus and EPS Surprise
SBRA 16.96 +0.23(1.37%)
Will SBRA be a Portfolio Killer in December?
Zacks Investment Research is releasing its prediction for SBRA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SBRA
Sabra (SBRA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Sabra Healthcare (SBRA) Q3 FFO and Revenues Surpass Estimates
SBRA: What are Zacks experts saying now?
Zacks Private Portfolio Services
City Holding (CHCO) Tops Q3 Earnings and Revenue Estimates
MPW Stock Surges 33.9% in a Month: Should You Buy Now or Wait?
Ventas Secures Agreements With Kindred & ScionHealth for 23 LTACs
Other News for SBRA
CareTrust REIT: An Acquisition Titan That's Still A Buy For Long-Term Investors
Analyst Expectations For Sabra Health Care REIT's Future
Sabra Health Care REIT downgraded at Mizuho on increased regulatory risk, full valuations
NAV Monitor: U.S. Equity REITs End November At 6.5% Median Discount
Sabra Health Care just downgraded at Mizuho, here's why